期刊文献+

非洛地平缓释片治疗高血压患者500例疗效观察 被引量:1

Efficacy observation of Felodipine extended-release tablets in the treatment of 500 caseswith hypertension
下载PDF
导出
摘要 目的:探讨非洛地平缓释片治疗高血压的临床疗效。方法:选择本院2008年3月~2011年3月500例高血压患者,500例患者在参与该研究前先进行一个为期2周的观察期,在观察期间所有患者停用降压药,只服用复方丹参片作为安慰剂,3片/次,3次/d,然后采用口服非洛地平缓释片5mg,每天早餐后服用,2周后根据患者血压情况调整用药,改为2.5~5.0mg顿服。治疗期间不使用任何钙离子拮抗剂、血管紧张素转换酶抑制剂和β受体阻滞剂。以4周为1个疗程。结果:1个疗程后500例患者中355例显效,126例有效,19例无效,总有效率为96.2%。治疗过程中5例患者脚踝水肿,7例脸部潮红,所有患者肝肾功能均无明显变化。结论:非洛地平缓释片治疗高血压疗效明显,副作用小,临床上建议进一步使用。 Objective: To investigate the effect of felodipine extended-release tablets in hypertension. Methods: Five hundred cases from March 2008 to March 2011 were selected, before treatment all patients were disabled for the anti-hypertensive drugs for 2 weeks, and were given placebo (Danshen tablets), each 3 tablets, 3 times a day, then used oral felodipine extended release tablets 5 rag, taken daily after breakfast for 2 weeks, and then adjusted the medication plan according to blood pressure. Results: Five hundred patients after a course, 355 cases were markedly effective, 126 cases were effective, 19 cases were ineffective, the total effective rate was 96.2%. Five patients during treatment were ankle edema, 7 cases werefacial flushing, liver and kidney function in all patients had no significant changes. Conclusion: It is valuable about felodipine extended-release tablets in hypertension, the advantage of definite effect, and rapid recovery, it is worthy of further promotion in clinical.
作者 吴结红
出处 《中国当代医药》 2011年第35期84-85,共2页 China Modern Medicine
关键词 非洛地平缓释片 复方丹参片 高血压 疗效 Felodipine extended-release tablets Danshen tablets Hypertension Clinical curative effect
  • 相关文献

参考文献6

二级参考文献14

  • 1刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2620
  • 2张远慧.中国最新高血压防治指南解读[J].新医学,2005,36(8):437-439. 被引量:39
  • 3诸骏仁,王敬良,陶萍,刘国仗,王宪衍,王育本,戴闺柱,范维琥,张丽蓉,李俭春.非洛地平缓释片与维拉帕米缓释片降压疗效比较[J].中华心血管病杂志,1996,24(5):366-369. 被引量:23
  • 4[1]ToddPA, Faulds K. Felodipine A reniew of the pharmacology and therapeutic use of the extended release formuiation in cardi-vascular disorders. Drugs, 1992,44: 251
  • 5[2]Goadie AW,Gupta OP. Gray PL et al. A comparion of felodipine and nifedipine as monotherapy in patients with mild-to-moderate hypertension. Curr Ther Res, 1994,55 : 625
  • 6[3]Watts RW,Dufek A,Wing LM. Comparion of felodipine and enalapril monotherapy in essential hypertension. Blood Press, 1993,2 (1): 53
  • 7[4]Flygt G. Iong-term treatment of hypertension with felodipine. J Cardiovasc Pharmacol, 1990,15 (suppl 4): 103
  • 8[5]Reuter MK,Lorenz H,Verho P et al. Effects of felodipine ER, adihydropyridine calcium antagonist, on blood pressure and serum lipids. Curr Med Res Opin, 1998,14 (2): 97
  • 9Hansson L, Zanchetti A, Carruthers G, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial.Lancet, 1998, 351:1755-1762.
  • 10Hansson L, Zanchetti A, for the HOT Study Group. The Hypertension Optimal Treatment Study (the HOT Study).Blood Press, 1993,2:62-68.

共引文献2727

同被引文献9

引证文献1

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部